0GBP
79.35 MGBP
659.83 MGBP
507.55 M
About HUTCHMED (CHINA) LIMITED ORD USD0.1
Sector
CEO
Wei Guo Su
Headquarters
Hong Kong
Website
Employees (FY)
1.99 K
Founded
2000
ISIN
KYG4672N1198
FIGI
BBG000P4SQF9
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
HCM Learning experiencePlaying Trading Simulator:
Big time rookie mistake.
Bought 350 shares at $41.71 on 3JAN18. Price was falling.
Same day bought 500 shares at $39.93 in order to dilute my buying price.
I began studying the chart and saw my mistake.
On 5JAN18 I sold my shares using a trailing stop of 10 cents.
It exe
Tracking HCMI've been a long term holder of HCM since 2009. They are also listed on the FTSE AIM 100 LSE:HCM.
They have outperformed the NASDAQ BIOTECHNOLOGY INDEX INDEX:NBI
Now would be a good place to exit.
I will continue to hold for now, i am not trading this. It's included in my long term portfolio.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HCM is 271.10 GBX — it has decreased by 5.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HUTCHMED (CHINA) LIMITED ORD USD0.1 stocks are traded under the ticker HCM.
HUTCHMED (CHINA) LIMITED ORD USD0.1 is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for HUTCHMED (CHINA) LIMITED ORD USD0.1 has a max estimate of 7.14 GBX and a min estimate of 2.70 GBX.
HCM earnings for the last quarter are 0.15 GBX whereas the estimation was −0.08 GBX which accounts for 282.69% surprise. Estimated earnings for the next quarter are −0.09 GBX. See more details about HUTCHMED (CHINA) LIMITED ORD USD0.1 earnings.
HUTCHMED (CHINA) LIMITED ORD USD0.1 revenue for the last quarter amounts to 419.82 M GBX despite the estimated figure of 242.60 M GBX. In the next quarter revenue is expected to reach 250.18 M GBX.
Yes, you can track HUTCHMED (CHINA) LIMITED ORD USD0.1 financials in yearly and quarterly reports right on TradingView.
Like other stocks, HCM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUTCHMED (CHINA) LIMITED ORD USD0.1 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 1.99 K employees. See our rating of the largest employees — is HUTCHMED (CHINA) LIMITED ORD USD0.1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUTCHMED (CHINA) LIMITED ORD USD0.1 EBITDA is 21.13 M GBP, and current EBITDA margin is 3.05%. See more stats in HUTCHMED (CHINA) LIMITED ORD USD0.1 financial statements.